Combination strategies to maximize the benefits of cancer immunotherapy

Immunotherapies such as immune checkpoint blockade (ICB) and adoptive cell therapy (ACT) have revolutionized cancer treatment, especially in patients whose disease was otherwise considered incurable. However, primary and secondary resistance to single agent immunotherapy often results in treatment f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Shaoming, Zhang, Tian, Zheng, Lei, Liu, Hongtao, Song, Wenru, Liu, Delong, Li, Zihai, Pan, Chong-xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475356/
https://www.ncbi.nlm.nih.gov/pubmed/34579759
http://dx.doi.org/10.1186/s13045-021-01164-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8475356/
https://www.ncbi.nlm.nih.gov/pubmed/34579759
http://dx.doi.org/10.1186/s13045-021-01164-5

Ejemplares similares